What is it about?
This article introduces a new modified peptide that can be used to treat diabetes type 1 and 2
Featured Image
Why is it important?
It adds improvements on the way to treat diabetes
Read the Original
This page is a summary of: Pharmacological Effects of EGLP-1, a Novel Analog of Glucagon-Like Peptide-1, on Carbohydrate and Lipid Metabolism, Cellular Physiology and Biochemistry, January 2018, Karger Publishers,
DOI: 10.1159/000491978.
You can read the full text:
Contributors
The following have contributed to this page
